Linda S. Avey

23andMe, Inc. provides genetic information using DNA analysis technologies and web-based interactive tools. It enables individuals to gain deeper insights into personal ancestry, genealogy, and inherited traits. The company was founded by Linda Avey, Paul L. Cusenza and Anne E. Wojcicki in 2006 and is headquartered in Sunnyvale, CA.

Affymetrix, Inc. develops, manufactures and sells products and services for genetic analysis. The company was founded by Stephen P. A. Fodor in 1992 and is headquartered in Santa Clara, CA.

Perlegen Sciences, Inc. discovers and develops drugs. Its product pipeline consists of targeted drug candidates addressing type II diabetes and dyslipidemia markets. The company's products include PGX-510 and PGX-520. It operates in the United States, European Union, and Japan. Perlegen Sciences was co-founded by Brad A. Margus, David R. Cox, and Stephen P. A. Fodor in 2000 and is headquartered in Mountain View, CA

Spotfire, Inc. provides analytic software solutions. It creates software that transforms complex data into images that reveal the relationships between pieces of information. The firm also offers installation, training workshops, and technical support services. The company was founded by Jonas Lagerblad and Christopher Ahlberg in 1996 and is headquartered in Boston, MA.

Applied Biosystems, Inc. is a company that provides integrated systems for sequencing, flow cytometry, and various types of PCR. The company is based in Foster City, CA. The company's products cover the entire process from sample preparation to data analysis. The company was founded by Chris Yoo, Marvin H. Caruthers, Michael W. Hunkapiller, and Leroy E. Hood. Applied Biosystems was acquired by Invitrogen Corp. from Applera Corp. on November 21, 2008 for $6,417.85 million.

Precise.ly, Inc. develops personal data tracking and integrating platform. It is comprised of web and app-based tools designed to streamline the importing of data from wearables, genome sequencing, environmental monitors and tracked events and activities. The platform also helps users and researchers to create group tracking protocols, with consented data-sharing options. The company was founded by Hadeishi Mitsuharu, Heather A. Halpert and Linda S. Avey in 2011 and is headquartered in Woodside, CA.

Perlara PBC manufactures orphan drugs. It solves the unmet medical needs of orphan disease patients with a scalable drug candidate generator that leaves no mutation behind. The company was founded by Ethan Perlstien in February 2014 and is headquartered in San Francisco, CA.

Giant Ventures Global LLP (Giant Ventures) is a venture capital firm founded in 2019 by Cameron McLain and Tommy Stadlen. The firm is headquartered in London, United Kingdom.